Target intelligence / Profile preview

DNA polymerase (DNAP) (DNAP)

Target
DNAP
Molecular classification
Enzyme, Transferase, DNA-directed DNA polymerase
01

Overview

DNA polymerases are essential enzymes that catalyze the synthesis of DNA molecules from deoxyribonucleotides, playing a central role in DNA replication and repair (UniProt). They function by adding nucleotides to the 3'-OH end of a growing DNA strand, guided by a template strand (NIH). In therapeutic contexts, the DNA polymerase active site is a major target for antiviral and anticancer drugs (PubChem). Nucleoside analogs, such as acyclovir and cytarabine, act as suicide substrates that are incorporated into the DNA, leading to chain termination or inhibition of further synthesis (StatPearls). Because cancer cells and viruses rely heavily on rapid DNA replication, these inhibitors can selectively disrupt their proliferation (PubMed). However, challenges include off-target effects on host cell polymerases, such as mitochondrial DNA polymerase gamma, which can lead to significant toxicities like myelosuppression and organ damage (NIH).

Other names
DNA-directed DNA polymeraseReplisomeDNA nucleotidyltransferaseDNA synthesis machineryDNA replication complex
02

Mechanism of action

Drugs targeting DNA polymerases primarily act as nucleoside or nucleotide analogs that compete with natural substrates for the active site. Upon incorporation into the nascent DNA strand, they typically cause premature chain termination or inhibit the enzyme's catalytic activity. Other mechanisms include allosteric inhibition and mimicry of pyrophosphate to block the release of the byproduct during nucleotide addition.

03

Biological functions

DNA replicationDNA repairCell cycleCell proliferationTranslesion synthesis
04

Disease associations

CancerViral infectionBacterial infectionAutoimmune disease
05

Safety considerations

MyelosuppressionNephrotoxicityMitochondrial toxicityGastrointestinal toxicityNeurotoxicity
06

Interacting drugs

Cytarabine

9 more in the full profile.

07

Biomarkers

PCNA (Proliferating Cell Nuclear Antigen)Ki-67DNA polymerase theta (Polθ) expressionBRCA1/2 mutation status

Beyond the preview

Go deeper on DNA polymerase (DNAP) (DNAP).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on DNA polymerase (DNAP) (DNAP).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call